市場調查報告書
商品編碼
1496710
輸液幫浦市場:按產品、模式、操作、應用和最終用戶分類 - 全球預測,2024-2030 年Infusion Pumps Market by Product (Ambulatory Infusion Pump, Enteral Infusion Pump, Implantable Infusion Pump), Mode (Portable Infusion Pump, Stationary Infusion Pump), Operation, Application, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年全球輸液幫浦市場規模為180.3億美元,2024年達192.5億美元,預計2030年將達293.6億美元,複合年成長率為7.21%。
輸液幫浦是醫療設備,用於以受控和精確的方式將藥物、營養液或水合液等液體輸送到患者體內。這些幫浦設計用於在特定時間段內控制液體量,以確保準確給藥和連續給藥,具體取決於患者的治療計劃。輸液幫浦通常用於醫院、家庭護理機構和診所,用於施用化療藥物、抗生素、止痛藥、胰島素或其他需要控制劑量的治療藥物。由於慢性病的日益普及和老年人口的不斷增加,輸液幫浦對方便的藥物輸送產生了迫切的需求。然而,輸液幫浦用藥錯誤的發生率、產品認證的嚴格監管要求以及輸液幫浦設備的高成本阻礙了輸液幫浦的發展。市場相關人員不斷進行研究和開發,以提高輸液幫浦的功能,同時提供具有成本效益的產品來解決這些限制。開拓具有增強安全功能和無線連接的智慧輸液幫浦系統市場,為市場擴張提供了進一步的機會。輸液幫浦與電子健康記錄(EMR) 整合、使用者友善介面的開發和智慧警報等創新為輸液幫浦帶來了商機。
主要市場統計 | |
---|---|
基準年[2023] | 180.3億美元 |
預測年份 [2024] | 192.5億美元 |
預測年份 [2030] | 293.6億美元 |
複合年成長率(%) | 7.21% |
區域洞察
美洲地區的特點是醫療基礎設施強大、政府和多個主要企業的醫療保健支出高,推動了輸液幫浦的成長和需求。此外,該地區致力於不斷的產品創新,美國食品藥物管理局(FDA) 等監管機構經常簡化輸液醫療設備的核准。此外,技術創新正在推動智慧技術和無線監控在輸液設備中的整合。歐盟國家受益於確保輸液設備品質和安全的高醫療保健標準和嚴格法規。成員國之間的合作以及對醫療保健技術的重大投資正在推動歐盟輸液泵的研究和發展。歐盟對個人化醫療和居家輸液治療的需求也在增加。由於醫療保健成本不斷上升以及人們對先進治療方法的認知不斷增強,亞太地區是一個快速成長的市場。中國、日本和印度等國家正在為該地區的擴張做出貢獻。在中國,政府推動醫療保健現代化和擴大農村地區醫療服務覆蓋範圍的努力正在推動市場成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在輸液幫浦市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對輸液幫浦市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
戰略分析和建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前輸液幫浦市場地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[191 Pages Report] The Infusion Pumps Market size was estimated at USD 18.03 billion in 2023 and expected to reach USD 19.25 billion in 2024, at a CAGR 7.21% to reach USD 29.36 billion by 2030.
An infusion pump is a medical device used to deliver fluids, such as medications, nutrients, or liquids for hydration, into a patient's body in a controlled and precise manner. These pumps are designed to administer liquids in controlled amounts over specific periods, ensuring accurate dosing and continuous delivery as required by the patient's treatment plan. Infusion pumps are commonly used in hospitals, homecare settings, and clinics for delivering chemotherapy drugs, antibiotics, pain relievers, insulin, or other therapies requiring regulated administration. The increasing prevalence of chronic diseases and rising elderly population has established a significant need for infusion pumps for convenient delivery of medications. However, the occurrence of medication errors associated with infusion pumps, stringent regulatory requirements for product approval, and the high cost of infusion pump devices impede the development of infusion pumps. Market players are working on consistent R&D to improve the capabilities of infusion pumps while offering cost-effective products to address these limitations. Developing smart infusion pump systems with enhanced safety features and wireless connectivity presents additional opportunities for market expansion. Innovations such as integrating infusion pumps with electronic medical records (EMR), developing user-friendly interfaces, and smart alarms form opportunities for infusion pumps.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 18.03 billion |
Estimated Year [2024] | USD 19.25 billion |
Forecast Year [2030] | USD 29.36 billion |
CAGR (%) | 7.21% |
Regional Insights
The Americas region is characterized by a robust healthcare infrastructure, high government healthcare spending, and several key players, thereby driving the region's growth and demand for infusion pumps. The region is also involved in constant product innovations, and regulatory bodies such as the Food and Drug Administration (FDA) frequently streamline medical device approvals for infusion pumps. Furthermore, technological innovations have fuelled the integration of smart technologies and wireless monitoring in infusion devices. EU countries benefit from high healthcare standards and stringent regulations that ensure the quality and safety of infusion devices. Collaborations amongst member states and substantial investment in healthcare technology drive research and development for infusion pumps in the EU. The EU also experiences a rising demand for personalized medicine and home infusion therapy. The Asia-Pacific region is experiencing rapid market growth due to rising healthcare expenditures and increasing awareness of advanced therapeutic options. Countries such as China, Japan, and India contribute to the region's expansion. In China, government initiatives to modernize healthcare and expand rural access have bolstered the market growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Infusion Pumps Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Infusion Pumps Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Infusion Pumps Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Fresenius Kabi, Mayo Clinic ink Deal On Ivenix Infusion System
Fresenius Kabi has joined forces with the esteemed Mayo Clinic to implement the innovative Ivenix Infusion System. This state-of-the-art technology promises to revolutionize the infusion pump market by offering advanced safety features and an intuitive user interface to minimize medication errors and enhance patient care. The partnership highlights a collaborative commitment to clinical excellence, with the Ivenix system as a critical component in facilitating effective, real-time infusion data integration into electronic medical records (EMRs), thus enabling healthcare professionals to deliver high-quality, efficient patient care. [Published On: 2023-12-15]
Tandem Diabetes Care Launches First Automated Insulin Pump Integrated With Dexcom G7 CGM
Tandem Diabetes Care has announced the launch of an advanced automated insulin delivery system. This new offering, combined with the Dexcom G7 continuous glucose monitoring (CGM) system, embodies a landmark in precision medicine, providing diabetes patients with a more autonomous and personalized treatment solution. Leveraging cutting-edge algorithms, the system automates insulin delivery with heightened accuracy, enhancing the user's control over their glucose levels without constant manual adjustments. The union of Tandem's automated insulin pump with Dexcom's CGM system is emblematic of the strides being made in the field of diabetes care, where innovation is directly translating to improved quality of life for individuals living with this chronic illness. [Published On: 2023-12-06]
Monidor Expands Remote IV Therapy Monitoring in Collaboration with B. Braun
Monidor has enhanced its market presence by partnering with B. Braun SE to advance remote IV therapy monitoring. Leveraging Monidor's expertise and B. Braun's extensive distribution network, this partnership aims to optimize infusion therapies and improve patient care. Integrating Monidor's Monidrop device and the MoniView software with B. Braun's infusion systems facilitates accurate administration and oversight of IV fluids remotely, thus ensuring precise dosing and reducing the likelihood of manual errors. [Published On: 2023-08-29]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Infusion Pumps Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Infusion Pumps Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Avanos Medical, Inc., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Bio-x, Boston Scientific Corporation, Canadian Hospital Specialties Limited, Chemyx Inc., Epic Medical Pty Ltd., Fresenius Se & Co. KGaA, FUJIFILM Corporation, GE HealthCare Technologies Inc., ICU Medical, Inc., Insulet Corporation, Intera Oncology, Inc., Intuvie Holdings LLC, Ivenix, Inc., JMS Co., Ltd., Longer Precision Pump Co. Ltd. by Halma PLC, Medline Industries, LP, Medtronic PLC, Merck KGaA, Micrel Medical Devices SA, Moog Inc., Narang Medical Limited, New Era Pump Systems Inc., Nipro Corporation, Shenzhen MedRena Biotech Co., Ltd., SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD., Siemens AG, SOOIL Developments Co., Ltd., Tandem Diabetes Care, Inc., Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., and Ypsomed AG.
Market Segmentation & Coverage